The impact of immunotherapy on reductions in cancer mortality: Evidence from Medicare
{{output}}
Immunotherapy is a breakthrough innovation in cancer care, but it is also among the most expensive treatments, with costs exceeding $150,000 per patient. We study the introduction of immune checkpoint inhibitors (ICIs), the most widely used class of immunother... ...
